These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18035782)

  • 1. Informal consultation on rifampicin resistance in leprosy.
    Lepr Rev; 2007 Sep; 78(3):295-305. PubMed ID: 18035782
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to 'Elimination of leprosy in India: An analysis'.
    Kumar B
    Indian J Dermatol Venereol Leprol; 2018; 84(4):443-444. PubMed ID: 29893302
    [No Abstract]   [Full Text] [Related]  

  • 3. Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy.
    Mieras L; Anthony R; van Brakel W; Bratschi MW; van den Broek J; Cambau E; Cavaliero A; Kasang C; Perera G; Reichman L; Richardus JH; Saunderson P; Steinmann P; Yew WW
    Infect Dis Poverty; 2016 Jun; 5(1):46. PubMed ID: 27268059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary report of a drug trial conducted at Leprosy Relief Rural Centre, Chettipatty, South India.
    Vomstein E
    Lepr Rev; 1975 Jun; 46(2 Suppl):207-13. PubMed ID: 1100962
    [No Abstract]   [Full Text] [Related]  

  • 5. Leprosy postexposure prophylaxis with single-dose rifampicin: Nepalese dermatologist's dilemma.
    Parajuli N; Poudyal Y
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009039. PubMed ID: 33830989
    [No Abstract]   [Full Text] [Related]  

  • 6. [How should leprosy be treated?].
    Mahé A
    Ann Dermatol Venereol; 1998 Dec; 125(12):881-3. PubMed ID: 9922859
    [No Abstract]   [Full Text] [Related]  

  • 7. Report of rpoB mutation in clinically suspected cases of drug resistant leprosy: a study from Eastern India.
    Hasanoor Reja AH; Biswas N; Biswas S; Lavania M; Chaitanya VS; Banerjee S; Maha Patra PS; Gupta UD; Patra PK; Sengupta U; Bhattacharya B
    Indian J Dermatol Venereol Leprol; 2015; 81(2):155-61. PubMed ID: 25751332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy.
    Joseph P; Ponnaiya J; Das M; Chaitanya VS; Arumugam S; Ebenezer M
    Indian J Lepr; 2016; 88(3):147-58. PubMed ID: 30207440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifampicin/minocycline and ofloxacin (ROM) for single lesions--what is the evidence?
    Lockwood DN
    Lepr Rev; 1997 Dec; 68(4):299-300. PubMed ID: 9503865
    [No Abstract]   [Full Text] [Related]  

  • 10. Present situation of leprosy in Japan, 2006-2010: analysis of drug resistance in new registered and relapsed cases by molecular biological methods.
    Mori S; Yotsu RR; Suzuki K; Makino M; Ishii N
    J Dermatol Sci; 2012 Sep; 67(3):192-4. PubMed ID: 22739027
    [No Abstract]   [Full Text] [Related]  

  • 11. The Role of Rifampin in Leprosy : Leprosy Through a New Lens.
    Allen HB; Moschella SL
    JAMA Dermatol; 2017 Mar; 153(3):261-262. PubMed ID: 28196219
    [No Abstract]   [Full Text] [Related]  

  • 12. An unusual reaction to rifampicin in a once monthly dose.
    Sule RR
    Lepr Rev; 1996 Sep; 67(3):227-8. PubMed ID: 8885617
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chemotherapy of leprosy. II. Sulfones and sulfonamides].
    Leiker DL
    Ned Tijdschr Geneeskd; 1980 Jan; 124(2):46-8. PubMed ID: 7374822
    [No Abstract]   [Full Text] [Related]  

  • 14. Relapse of multibacillary leprosy after treatment with daily rifampin plus ofloxacin for four weeks.
    Ji B
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):391-2. PubMed ID: 9934368
    [No Abstract]   [Full Text] [Related]  

  • 15. Co-existence of mycobacterial infections: is it an emerging issue with retroviral infections?
    Keragala B; Herath H; Janappriya G; Gunasekera CN
    Trop Doct; 2019 Apr; 49(2):145-146. PubMed ID: 30582730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].
    Sansarricq H
    Acta Leprol; 1986; 4(3):355-62. PubMed ID: 3551474
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of leprosy today].
    Bahmer FA; Menzel S
    Hautarzt; 1987 Jan; 38(1):1-3. PubMed ID: 3557977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global practices in regard to implementation of preventive measures for leprosy.
    Gillini L; Cooreman E; Wood T; Pemmaraju VR; Saunderson P
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005399. PubMed ID: 28472183
    [No Abstract]   [Full Text] [Related]  

  • 19. Images in clinical tropical medicine. Multibacillary leprosy in Zambia.
    Zargaran E
    Am J Trop Med Hyg; 2009 Aug; 81(2):189. PubMed ID: 19635867
    [No Abstract]   [Full Text] [Related]  

  • 20. Committee 4: workshop on experimental chemotherapy of leprosy.
    Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2 Suppl):297-303. PubMed ID: 378876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.